Product Reports Resources Pricing Login Book a demo

Biogena

Biotech & Life Sciences · Salzburg, Austria · Founded 2006

Focusing on products and services that help everyone around the world to achieve better health and well-being and the best possible development of their potential

Valuation $0–100M
Revenue $50–100M
Headcount 100–500
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Biogena and the history behind them.
Power Law Colt$25–100M revenue

Talent graph

Biogena's talent

Book a demo to see the people
Employees mapped 243 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 34 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on Biogena's cap table

Sourced from Dealroom's funding and investor records.

Series A 1 investor entered at this stage
Invesdor
Series B+ 1 investor entered at this stage
Tauros Capital

Global footprint

Where Biogena has talent and traffic

Workforce by country
🇦🇹 Austria · Salzburg HQ
Book a demo for the full country breakdown
Web traffic by country
760K monthly visits
across markets
🇩🇪 Germany26.2%
🇦🇹 Austria21.2%
🇮🇹 Italy13.3%
🇫🇷 France4.2%
🇨🇭 Switzerland3.1%
Top 5 markets shown

Capital deployed

Biogena's 5 investments and acquisitions.

Every disclosed deal where Biogena appeared as a backer or acquirer, 2021–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Biogena's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Biogena's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        What the market is saying about Biogena

        An AI-synthesized read of the highest-engagement posts about Biogena on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Biogena on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles